Profit of BioNTech 2017-2023
In 2023, the annual profit of biotech company BioNTech SE was 930 billion euros, compared to around 9.4 billion euros in the previous year. This statistic illustrates the profit (after income taxes) of BioNTech SE from 2017 to 2023. On November 9th 2020, German biotech company BioNTech in cooperation with U.S. pharma giant Pfizer were the first to announce a proven COVID-19 vaccine to be ready for mass production by year-end.